Dr. Kristen Marie Kelly, MD

Dr. Kelly practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Kelly's NPI, 1265448609, was assigned on July 31, 2006. Dr. Kelly graduated from David Geffen School of Medicine at UCLA in 1993. Dr. Kelly holds California license G80021.

Dr. Kelly's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Kelly's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Dermatology Services.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kelly practices. Vendor and product names are available with a free account.

Dermatology is Dr. Kelly's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kelly is board certified in dermatology by the American Board of Dermatology. Dr. Kelly is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, hives and itchy rashes among the conditions Dr. Kelly treats.

CMS data shows 2,003 Medicare services from Dr. Kelly across 11 procedure codes in 2024, for 380 Medicare patients. Medicare paid $95,543 for them. Every service was in an office.

CMS counts 380 Medicare patients who saw Dr. Kelly in 2024. The largest group is 65 to 74, with 179 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 8% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kelly's median patient age at 61, with 60% women.

In 2024, Dr. Kelly wrote 483 Medicare Part D claims for 178 patients. 88% of them were for generic drugs. CMS names the drug for 398 of them, across 14 drugs with 11 or more claims each, at $158,065 in total drug cost. In 2023, CMS named 259 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kelly for performance year 2024, reported through an alternative payment model (APM). Dr. Kelly accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 410 procedures of removal of skin lesions by Dr. Kelly, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 146 papers to Dr. Kelly, published from 2007 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Skin, Port-Wine Stain and Laser Therapy. Dr. Kelly has published most often in Lasers Surg Med. Dr. Kelly's most frequent co-authors are Christopher Bransby Zachary, MD, Roy G. Geronemus, MD and Ronald M. Harris, MD.

Dmand AI links Dr. Kelly to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Skin Diseases, Hemangioma, Capillary and Skin Neoplasms. University of California, Irvine sponsors the most, 4.

CMS Open Payments shows 5 general payments to Dr. Kelly from 3 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 73% of the total. Allergan Inc. paid the most, $2,271.

Dmand AI lists 20 awards for Dr. Kelly, most recently Leon Goldman Memorial Award, to recognize a practicing physician whose career demonstrates excellence in lasers in 2018.

Dr. Kelly graduated from David Geffen School of Medicine at UCLA in 1993. Dr. Kelly is a member of AAD and ASDS.

Dr. Kelly is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.